Shares of Omnicare (NYSE:OCR) traded at a new 52-week high today of $93.30. So far today approximately 1 million shares have been exchanged, as compared to an average 30-day volume of 1.5 million shares.
Omnicare, Inc. provides geriatric pharmaceutical services. The Company distributes pharmaceuticals, and provides related pharmacy consulting and other ancillary services, data management services and medical supplies to skilled nursing facilities, assisted living facilities, retirement centers, independent living communities, hospitals, hospice, and other healthcare providers.
In the past 52 weeks, shares of Omnicare have traded between a low of $59.85 and a high of $93.30 and are now at $92.80, which is 55% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.8% while the 50-day MA has advanced 1.5%.
Omnicare (NYSE:OCR) is currently priced 4.1% above its average consensus analyst price target of $89.00. The stock should discover initial support at its 50-day moving average (MA) of $80.96 and subsequent support at its 200-day MA of $71.70.